{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T07:38:14Z","timestamp":1740123494881,"version":"3.37.3"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,9,7]],"date-time":"2021-09-07T00:00:00Z","timestamp":1630972800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,9,7]],"date-time":"2021-09-07T00:00:00Z","timestamp":1630972800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. U1803125"],"award-info":[{"award-number":["No. U1803125"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program","doi-asserted-by":"crossref","award":["No. 2019YFE0113500"],"award-info":[{"award-number":["No. 2019YFE0113500"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drugs Ther"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s10557-021-07206-x","type":"journal-article","created":{"date-parts":[[2021,9,7]],"date-time":"2021-09-07T08:02:50Z","timestamp":1631001770000},"page":"1109-1119","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["HPMC improves protective effects of naringenin and isonicotinamide co-crystals against abdominal aortic aneurysm"],"prefix":"10.1007","volume":"36","author":[{"given":"Xing","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaotong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunxia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gulinigaer","family":"Anwaier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang","family":"Di","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0627-9968","authenticated-orcid":false,"given":"Rong","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanbin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,9,7]]},"reference":[{"issue":"6","key":"7206_CR1","doi-asserted-by":"publisher","first-page":"441","DOI":"10.7326\/0003-4819-126-6-199703150-00004","volume":"126","author":"FA Lederle","year":"1997","unstructured":"Lederle FA, Johnson GR, Wilson SE, Chute EP, Littooy FN, Bandyk D, et al. Prevalence and associations of abdominal aortic aneurysm detected through screening. Aneurysm Detection and Management (ADAM) Veterans Affairs Cooperative Study Group. Ann Intern Med. 1997;126(6):441\u20139.","journal-title":"Ann Intern Med"},{"issue":"8","key":"7206_CR2","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1161\/01.ATV.16.8.963","volume":"16","author":"HG Alcorn","year":"1996","unstructured":"Alcorn HG, Wolfson SK, Sutton-Tyrrell K, Kuller LH, Oleary D. Risk factors for abdominal aortic aneurysms in older adults enrolled in The Cardiovascular Health Study. Arterioscler Thromb Vasc Biol. 1996;16(8):963\u201370.","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"7206_CR3","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.jss.2016.06.018","volume":"209","author":"L Tang","year":"2017","unstructured":"Tang L, Cong Z, Hao S, Li P, Huang H, Shen Y, et al. Protective effect of melatonin on the development of abdominal aortic aneurysm in a rat model. J Surg Res. 2017;209:266.","journal-title":"J Surg Res."},{"issue":"9-10","key":"7206_CR4","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1002\/prca.201400051","volume":"8","author":"NM Htun","year":"2015","unstructured":"Htun NM, Peter K. Biomarkers for AAA: Encouraging steps but clinical relevance still to be delivered. Proteom Clin Appl. 2015;8(9-10):732\u20134.","journal-title":"Proteom Clin Appl."},{"issue":"11","key":"7206_CR5","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1016\/0895-4356(95)00045-3","volume":"48","author":"RF Gillum","year":"1995","unstructured":"Gillum RF. Epidemiology of aortic aneurysm in the United States. J Clin Epidemiol. 1995;48(11):1289\u201398.","journal-title":"J Clin Epidemiol."},{"issue":"12","key":"7206_CR6","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1002\/bjs.4342","volume":"90","author":"VA Best","year":"2010","unstructured":"Best VA, Price JF, Fowkes FGR. Persistent increase in the incidence of abdominal aortic aneurysm in Scotland, 1981-2000. Br J Surg. 2010;90(12):1510\u20135.","journal-title":"Br J Surg."},{"issue":"6","key":"7206_CR7","first-page":"1292","volume":"25","author":"Y Liu","year":"2008","unstructured":"Liu Y. Study on the preparation method of naringenin. Chin J Spectr Lab. 2008;25(6):1292\u20134.","journal-title":"Chin J Spectr Lab."},{"issue":"1","key":"7206_CR8","first-page":"106","volume":"28","author":"XF Chen","year":"2007","unstructured":"Chen XF, Liu D, Li X. Study on supercritical CO2 extraction rocess of nagringenin from peach leaf. Food Sci. 2007;28(1):106\u20139.","journal-title":"Food Sci."},{"issue":"2","key":"7206_CR9","first-page":"193","volume":"36","author":"WY Liu","year":"2012","unstructured":"Liu WY, Huo P, Mei GQ, Xiong ZX, Wang RJ. The study on microwave synthesis and antibacterial activity of Hhesperetin aromatic hydrazone compounds. J Jiangxi Norm Univ. 2012;36(2):193\u20135.","journal-title":"J Jiangxi Norm Univ"},{"issue":"4","key":"7206_CR10","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.fct.2013.04.024","volume":"58","author":"Y Chen","year":"2013","unstructured":"Chen Y, Nie YC, Luo YL, Lin F, Zheng YF, Cheng GH, et al. Protective effects of naringin against paraquat-induced acute lung injury and pulmonary fibrosis in mice. Food Chem Toxicol. 2013;58(4):133\u201340.","journal-title":"Food Chem Toxicol."},{"key":"7206_CR11","unstructured":"Kong W, Cui Q, Liu Z, Yu F, inventors; Use of naringenin in preparing drugs for preventing and\/or treating abdominal aortic aneurysm. China patent WO 2014\/206056 A1. 2014.12.31."},{"key":"7206_CR12","first-page":"625","volume":"04","author":"S Liang","year":"2017","unstructured":"Liang S, Zhou S, Yang S, Xia D, Wei Y, Gao Y, et al. Thermodynamic studies of naringenin-isonicotinamide cocrystals. Acta Pharm Sin. 2017;04:625\u201333.","journal-title":"Acta Pharm Sin."},{"issue":"3","key":"7206_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1208\/s12249-019-1324-0","volume":"20","author":"WX Cui","year":"2019","unstructured":"Cui WX, He ZH, Zhang YT, Fan QY, Feng NP. Naringenin cocrystals prepared by solution crystallization method for improving bioavailability and anti-hyperlipidemia effects. AAPS PharmSciTech. 2019;20(3):1\u201312.","journal-title":"AAPS PharmSciTech."},{"issue":"1","key":"7206_CR14","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1159\/000225695","volume":"40","author":"B Toth","year":"1983","unstructured":"Toth B. Lack of carcinogenicity of nicotinamide and isonicotinamide following lifelong administration to mice. Oncology. 1983;40(1):72\u20135.","journal-title":"Oncology"},{"key":"7206_CR15","doi-asserted-by":"crossref","unstructured":"Fukaya M, Tamura Y, Chiba Y, Tanioka T, Kaneki MJB. Protective effects of a nicotinamide derivative, isonicotinamide, against streptozotocin-induced \u03b2-cell damage and diabetes in mice. Biochem Biophys Res Commun. 2013;442(1\u20132).","DOI":"10.1016\/j.bbrc.2013.11.024"},{"key":"7206_CR16","unstructured":"Rowe R, Sheskey P, Quinn M. Handbook of Pharmaceutical Excipients. 6th ed. London: Pharmaceutical Press; 2009."},{"key":"7206_CR17","unstructured":"Zhang J, Xia D, Xu J, Gao Y, inventors; Naringenin isonicotinic acid eutectic. China patent CN 104817526 A. 2015.08.05."},{"issue":"9","key":"7206_CR18","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1016\/j.xphs.2016.03.024","volume":"105","author":"DD Sun","year":"2016","unstructured":"Sun DD, Wen H, Taylor LS. Non-sink dissolution conditions for predicting product quality and in\u00c2 vivo performance of supersaturating drug delivery systems. J Pharm Sci. 2016;105(9):2477\u201388.","journal-title":"J Pharm Sci."},{"issue":"2","key":"7206_CR19","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1111\/bph.14515","volume":"176","author":"Y Wang","year":"2019","unstructured":"Wang Y, Chen C, Wang Q, Cao Y, Xu L, Qi R. Inhibitory effects of cycloastragenol on abdominal aortic aneurysm and its related mechanisms. Br J Pharmacol. 2019;176(2):282\u201396.","journal-title":"Br J Pharmacol."},{"issue":"15","key":"7206_CR20","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.2217\/nnm-2017-0119","volume":"12","author":"C Chen","year":"2017","unstructured":"Chen C, Jie X, Ou Y, Cao Y, Xu L, Wang Y, et al. Nanoliposome improves inhibitory effects of naringenin on nonalcoholic fatty liver disease in mice. Nanomedicine. 2017;12(15):1791\u2013800.","journal-title":"Nanomedicine."},{"issue":"5","key":"7206_CR21","doi-asserted-by":"publisher","first-page":"772","DOI":"10.3109\/03639045.2014.902466","volume":"41","author":"AW Khan","year":"2015","unstructured":"Khan AW, Kotta S, Ansari SH, Sharma RK, Ali J. Enhanced dissolution and bioavailability of grapefruit flavonoid Naringenin by solid dispersion utilizing fourth generation carrier. Drug Dev Ind Pharm. 2015;41(5):772.","journal-title":"Drug Dev Ind Pharm."},{"key":"7206_CR22","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.3109\/03639048809152019","volume":"14","author":"KH Ziller","year":"1988","unstructured":"Ziller KH, Rupprecht H. Control of crystal growth in drug suspensions. Drug Dev Ind Pharm. 1988;14:2341\u201370.","journal-title":"Drug Dev Ind Pharm."},{"issue":"2","key":"7206_CR23","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1021\/cg501784n","volume":"15","author":"X Yang","year":"2015","unstructured":"Yang X, Shen B, Huang Y. Mechanistic study of HPMC-prolonged supersaturation of hydrocortisone. Cryst Growth Des. 2015;15(2):546\u201351.","journal-title":"Cryst Growth Des."},{"issue":"7","key":"7206_CR24","doi-asserted-by":"publisher","first-page":"2662","DOI":"10.1021\/cg200492w","volume":"11","author":"JN Babu","year":"2011","unstructured":"Babu JN, Nangia A. Solubility advantage of amorphous drugs and pharmaceutical cocrystals. Cryst Growth Des. 2011;11(7):2662\u201379.","journal-title":"Cryst Growth Des."},{"key":"7206_CR25","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.addr.2016.04.022","volume":"101","author":"G Kuminek","year":"2016","unstructured":"Kuminek G, Cao F, Rocha ABDOD, Cardoso SG, Rodr\u00edguez-Hornedo N. Cocrystals to facilitate delivery of poorly soluble compounds beyond-rule-of-5. Adv Drug Deliv Rev. 2016;101:143\u201366.","journal-title":"Adv Drug Deliv Rev."},{"issue":"1","key":"7206_CR26","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1021\/acs.molpharmaceut.8b00923","volume":"16","author":"MS Jasani","year":"2019","unstructured":"Jasani MS, Kale DP, Singh IP, Bansal AK. Influence of drug-polymer interactions on dissolution of thermodynamically highly unstable cocrystal. Mol Pharm. 2019;16(1):151\u201364.","journal-title":"Mol Pharm."},{"issue":"22","key":"7206_CR27","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1021\/cen-v088n022.p013","volume":"88","author":"AM Thayer","year":"2010","unstructured":"Thayer AM. Finding solutions. Chem Eng News. 2010;88(22):13\u20138.","journal-title":"Chem Eng News."},{"issue":"1","key":"7206_CR28","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1124\/pr.112.005660","volume":"65","author":"HD Williams","year":"2013","unstructured":"Williams HD, Trevaskis NL, Charman SA, Shanker RM, Charman WN, Pouton CW, et al. Strategies to address low drug solubility in discovery and development. Pharmacol Rev. 2013;65(1):315\u2013499.","journal-title":"Pharmacol Rev."},{"key":"7206_CR29","doi-asserted-by":"publisher","first-page":"2686","DOI":"10.1002\/jps.20906","volume":"96","author":"HR Guzm\u00e1n","year":"2007","unstructured":"Guzm\u00e1n HR, Tawa M, Zhang Z, Ratanabanangkoon P, Shaw P, Gardner CR, et al. Combined use of crystalline salt forms and precipitation inhibitors to improve oral absorption of celecoxib from solid oral formulations. J Pharm Sci. 2007;96:2686\u2013702.","journal-title":"J Pharm Sci."},{"key":"7206_CR30","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1002\/jps.21650","volume":"98","author":"J Brouwers","year":"2009","unstructured":"Brouwers J, Brewster ME, Augustijns P. Supersaturating drug delivery systems: the answer to solubility-limited oral bioavailability. J Pharm Sci. 2009;98:2549\u201372.","journal-title":"J Pharm Sci"},{"key":"7206_CR31","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1517\/17425247.3.1.97","volume":"3","author":"P Gao","year":"2006","unstructured":"Gao P, Morozowich W. Development of supersaturatable self-emulsifying drug delivery system formulations for improving the oral absorption of poorly soluble drugs. Expert Opin Drug Del. 2006;3:97\u2013110.","journal-title":"Expert Opin Drug Del."},{"key":"7206_CR32","first-page":"35","volume":"5","author":"L Bao","year":"2012","unstructured":"Bao L, Zhu J, Li Z. Effect of intraperitoneal fluid replacement on diarrhea in piglets. Agr Equip Tech. 2012;5:35\u20136.","journal-title":"Agr Equip Tech."}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-021-07206-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10557-021-07206-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-021-07206-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T11:06:35Z","timestamp":1668164795000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10557-021-07206-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,7]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["7206"],"URL":"https:\/\/doi.org\/10.1007\/s10557-021-07206-x","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"type":"print","value":"0920-3206"},{"type":"electronic","value":"1573-7241"}],"subject":[],"published":{"date-parts":[[2021,9,7]]},"assertion":[{"value":"24 May 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration"}},{"value":"The authors declare no conflicts of interest with other organizations or individuals regarding the content or publication of this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The Laboratory Animal Care Principles (NIH publication no. 85-23, revised 1996) were followed, and the experimental protocol was approved by the Animal Care Committee of Peking University Health Science Center.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}